Sarepta Therapeutics, Inc.

US$17.82As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SRPTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (7.58%)
Div yield —
ROE (8.05%)
Biotechnology
Beta (5Y) 0.46
PE TTM —
TSR TTM (25.78%)
Mkt cap US$1.911B
ROIC (0.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
(4.66%)
(3.87%)
Hold 7|2|10|10|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.29
0.29
0.30
0.30
20.41%
18.63%
11.87%
6.42%
Revenue$M
203.6
214.7
222.0
218.2
6.98%
7.87%
14.02%
6.15%
Peers (US$1.911B)
Cap (US$)
PE
1.944B
10.95x
Capital
TTM
5Y
10Y
Leveragex
0.535
2.618
2.625
EBIT/Intx
0.292
0.506
0.620
Own earn%
(101.05)
(130.42)
(128.99)
Sh yield%
38.79
41.73
40.94
Owners
Insiders/Inst%
9.22
51.27
Short interest%
2.33
SBC / revenue%
3.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
17–21
$1 testx
—
Incr. ROIC%
0